Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer
- PMID: 11459871
- DOI: 10.1093/jnci/93.14.1095
Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer
Abstract
Background: Although breast cancer screening is recommended to start at a younger age for women with a hereditary risk of breast cancer, the sensitivity of mammography for these women is reduced. We compared magnetic resonance imaging (MRI) with mammography to determine which is more sensitive and whether MRI could play a role in the early detection of breast cancer for these women.
Methods: We constructed a retrospective cohort of all breast MRI and mammography surveillance reports made in our department from November 1994 to February 2001. All of the 179 women in the cohort had received biannual palpation in addition to annual imaging by MRI, mammography, or both. The 258 MRI images and the 262 mammograms were classified with the use of the BI-RADS (i.e., Breast Imaging Reporting and Data System) scoring system, which has five categories to indicate the level of suspicion of a lesion. Receiver operator characteristic curves were generated for MRI and mammography, and the area under each curve (AUC) was assessed for the entire cohort of 179 women and for a subset of 75 women who had received both an MRI and a mammographic examination within a 4-month period. All statistical tests were two-sided.
Results: In the cohort of 179 women, we detected 13 breast cancers. Seven cancers were not revealed by mammography, but all were detected by MRI. For the entire cohort, the AUC for mammography was 0.74 (95% confidence interval [CI] = 0.68 to 0.79), and the AUC for MRI was 0.99 (95% CI = 0.98 to 1.0). For the subset of women who had both examinations, the AUC for mammography was 0.70 (95% CI = 0.60 to 0.80), and the AUC for MRI was 0.98 (95% CI = 0.95 to 1.0).
Conclusion: MRI was more accurate than mammography in annual breast cancer surveillance of women with a hereditary risk of breast cancer. Larger prospective studies to examine the role of MRI in screening programs are justified.
Comment in
-
Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.J Natl Cancer Inst. 2001 Nov 21;93(22):1754-5. doi: 10.1093/jnci/93.22.1754. J Natl Cancer Inst. 2001. PMID: 11717339 No abstract available.
Similar articles
-
The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.J Prim Care Community Health. 2017 Apr;8(2):55-62. doi: 10.1177/2150131916674889. Epub 2016 Oct 31. J Prim Care Community Health. 2017. PMID: 27799412 Free PMC article.
-
Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan. Report No.: 14-05201-EF-3. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan. Report No.: 14-05201-EF-3. PMID: 26866210 Free Books & Documents. Review.
-
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21. doi: 10.1093/jnci/djt203. Epub 2013 Aug 12. J Natl Cancer Inst. 2013. PMID: 23940285
-
Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.Invest Radiol. 2011 Feb;46(2):94-105. doi: 10.1097/RLI.0b013e3181f3fcdf. Invest Radiol. 2011. PMID: 21139507
-
A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.Eur J Cancer. 2007 Sep;43(13):1905-17. doi: 10.1016/j.ejca.2007.06.007. Epub 2007 Aug 2. Eur J Cancer. 2007. PMID: 17681781 Review.
Cited by
-
Motion-based microwave tomographic measurement device for three-dimensional coverage in a magnetic resonance system.Med Phys. 2022 Dec;49(12):7638-7647. doi: 10.1002/mp.15921. Epub 2022 Aug 26. Med Phys. 2022. PMID: 35964298 Free PMC article.
-
"High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis".Front Oncol. 2021 Sep 2;11:683656. doi: 10.3389/fonc.2021.683656. eCollection 2021. Front Oncol. 2021. PMID: 34540661 Free PMC article.
-
Prophylactic Surgery in the BRCA+ Patient: Do Women Develop Breast Cancer While Waiting?Curr Oncol. 2021 Jan 25;28(1):702-715. doi: 10.3390/curroncol28010069. Curr Oncol. 2021. PMID: 33504079 Free PMC article.
-
Evaluation of breast screening strategies in a high risk breast and ovarian cancer clinic.Gynecol Oncol Rep. 2020 May 22;33:100587. doi: 10.1016/j.gore.2020.100587. eCollection 2020 Aug. Gynecol Oncol Rep. 2020. PMID: 32490124 Free PMC article.
-
Breast cancer surveillance for BRCA1/2 mutation carriers - is "early detection" early enough?Breast. 2020 Feb;49:81-86. doi: 10.1016/j.breast.2019.10.012. Epub 2019 Nov 6. Breast. 2020. PMID: 31760168 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical